WASHINGTON--(BUSINESS WIRE)--Today, the Senate Committee on Banking, Housing, and Urban Affairs held a hearing on “Spurring Job Growth through Capital Formation While Protecting Investors, Part II.” On behalf of the Biotechnology Industry Organization (BIO) William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, Inc. presented testimony at the hearing on the importance of capital formation to encourage investment in the biotechnology industry and spur job growth across the country.
